Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 2
2003 1
2004 5
2005 3
2006 1
2007 4
2008 1
2009 3
2010 2
2011 4
2012 3
2014 7
2015 17
2016 13
2017 8
2018 5
2019 5
2020 5
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

79 results
Results by year
Filters applied: . Clear all
Page 1
Combination of copanlisib with cetuximab improves tumor response in cetuximab-resistant patient-derived xenografts of head and neck cancer.
Klinghammer K, Politz O, Eder T, Otto R, Raguse JD, Albers A, Kaufmann A, Tinhofer I, Hoffmann J, Keller U, Keilholz U. Klinghammer K, et al. Among authors: raguse jd. Oncotarget. 2020 Oct 13;11(41):3688-3697. doi: 10.18632/oncotarget.27763. eCollection 2020 Oct 13. Oncotarget. 2020. PMID: 33110476 Free PMC article.
Primary oral manifestation of Langerhans cell histiocytosis refractory to conventional therapy but susceptible to BRAF-specific treatment: a case report and review of the literature.
Neckel N, Lissat A, von Stackelberg A, Thieme N, Doueiri MS, Spors B, Beck-Broichsitter B, Heiland M, Raguse JD. Neckel N, et al. Among authors: raguse jd. Ther Adv Med Oncol. 2019 Oct 19;11:1758835919878013. doi: 10.1177/1758835919878013. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 31666812 Free PMC article.
79 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page